Stock Expert AI
Equity research screen

Best Mid-Cap Stocks for 2026

This page details a focused screen of mid-cap stocks, targeting companies with market capitalizations between $2 billion and $10 billion. These firms often represent a balance between established stability and high-growth potential. This 2026 shortlist is designed to surface companies demonstrating robust financial health and promising growth prospects, potentially offering attractive investment opportunities. The selection favors firms that exhibit strong fundamentals and are well-positioned to capitalize on emerging market trends.

This page presents a curated screen of mid-cap stocks for 2026, focusing on companies with market capitalizations between $2 billion and $10 billion. The shortlist is constructed using a methodology that prioritizes revenue growth, positive free cash flow, and overall financial health.
Stocks20Screens50Average score70.60UpdatedDaily
Data sources: Financial Modeling Prep | Yahoo Finance | SEC Filings 70,000+ securities analyzed

Screening for Mid-Cap Opportunities

Mid-cap stocks can offer a compelling risk-reward profile. They are typically past the riskiest startup phase but still possess considerable growth runway compared to larger, more established corporations. Identifying the best mid-cap stocks requires a focused screening approach that balances growth metrics with measures of financial stability. This approach aims to pinpoint companies with the potential to deliver outsized returns while mitigating downside risk.

Names rising to the top of the screen

The strongest names remain easy to scan without losing the valuation context behind the ranking.

1
SNDX Syndax Pharmaceuticals, Inc.
$22.80 +0.40% $2.0B Healthcare
79Score
2
ANAB AnaptysBio, Inc.
$58.00 +7.11% $2.5B Healthcare
79Score
3
NUVB Nuvation Bio Inc.
$5.80 +2.84% $2.0B Healthcare
73Score
4
LQDA Liquidia Corporation
$79.94 +6.20% $7.1B Healthcare
72Score
5
ONDS Ondas Holdings Inc.
$6.53 -1.88% $3.5B Technology
72Score
6
PTCT PTC Therapeutics, Inc.
$78.59 +0.09% $6.5B Healthcare
72Score
7
SII Sprott Inc.
$104.14 -0.37% $2.7B Financial Services
71Score
8
CRNX Crinetics Pharmaceuticals, Inc.
$83.86 -0.06% $8.9B Healthcare
71Score
9
LGND Ligand Pharmaceuticals Incorporated
$303.39 +2.34% $6.1B Healthcare
71Score
10
MCHB Mechanics Bank
$16.28 -2.16% $3.6B Financial Services
71Score
11
SLAB Silicon Laboratories Inc.
$217.47 -0.41% $7.2B Technology
69Score
12
ATAI Atai Beckley NV is a clinical-stage biopharmaceutical company focused on developing treatments for mental health disorders. The company
$7.22 +0.98% $2.7B Healthcare
68Score

Where valuation pressure is clustering

Healthcare65%Technology18%Financial Services12%Consumer Cyclical6%

Shortlist Context

This shortlist represents a snapshot of potentially attractive mid-cap companies based on current market data and financial metrics. However, investors should conduct their own due diligence and consider their individual risk tolerance before making any investment decisions. The market conditions and company-specific factors can change rapidly, influencing investment outcomes.

Questions worth resolving before acting on the screen

What defines a mid-cap stock?

/ Mid-cap stocks are generally defined as companies with market capitalizations between $2 billion and $10 billion. This range can vary slightly depending on the source.

Why invest in mid-cap stocks?

/ Mid-cap stocks often offer a balance between growth potential and stability, potentially providing attractive returns with moderate risk compared to small-cap or large-cap stocks.

What are the risks of investing in mid-cap stocks?

/ Mid-cap stocks can be more volatile than large-cap stocks and may be more susceptible to economic downturns or industry-specific challenges.

How often is this list updated?

/ The underlying data is refreshed periodically to reflect the most current market conditions and financial data. Please check the source timestamps.

Explore More Research

Stock Expert AI provides data and analysis tools for educational purposes. This is not financial advice. Past performance does not guarantee future results. Always consult a qualified financial advisor before making investment decisions. Data sources: Financial Modeling Prep, Yahoo Finance.